The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 19, 2022
Filed:
Dec. 09, 2015
Applicant:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Inventors:
Lieven Elvire Colette Baert, Bruges, BE;
Willy Albert Maria Carlo Dries, Merksplas, BE;
Laurent Bruno Schueller, Antwerp, BE;
Marc Karel Jozef Francois, Kapellen, BE;
Peter Jozef Maria Van Remoortere, Kapellen, BE;
Assignee:
Janssen Sciences Ireland Unlimited Company, County Cork, IE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23K 50/10 (2016.01); A23K 20/158 (2016.01); A61K 31/505 (2006.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 31/00 (2006.01); A61K 47/10 (2017.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 31/505 (2013.01); A61K 9/0019 (2013.01); A61K 9/14 (2013.01); A61K 9/145 (2013.01); A61K 9/146 (2013.01); A61K 31/00 (2013.01); A61K 47/10 (2013.01); A61K 47/34 (2013.01);
Abstract
This invention concerns pharmaceutical compositions for administration via intramuscular or subcutaneous injection, comprising micro- or nanoparticles of the NNRTI compound TMC278, suspended in an aqueous pharmaceutically acceptable carrier, and the use of such pharmaceutical compositions in the treatment and prophylaxis of HIV infection.